Join
Live feed
·
PRReleasevia Quantisnow
Upstream Bio Inc. logo

Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

ByQuantisnow·Wall Street's wire, on your screen.
UPB· Upstream Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track UPB (Upstream Bio Inc.) and more on Quantisnow.